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Enhancement of Influenza Virus Infections
by Secalonic Acid D
by Deborah S. Fleischhacker,*t Thomas G. Akers,*
Stephen R Katz,* and Muriel S. Palmgren*
Secalonic acid D (SAD), a hepatotoxic, teratogenic, and slightly mutagenic metabolite of Penicllium
oaxalicum has been identified as a natural contaminant of grain dust. Secalonic acid D was administered
intraperitoneally to male ICRmice thatwereexposedto influenzavirus aerosols 5days earlier. The mortality
rate was significantly higher (p < 0.001) in mice subjected to both influenza and SAD than those subjected
to influenza alone. Virus titers in lung tissue samples at selected time intervals appeared similar for both
influenza and influenza-SAD treated groups of mice for 9 days after exposure to the virus. After 9 days,
influenza-SAD treated miceappearedtohavehighervirustiters. Nodifferenceinthepathological progression
of pneumonia was discernible between these two groups of mice. The influenza-SAD group, in addition to
pneumonia, exhibited severe hepatic necrosis characteristic of SAD administration. Mice infected with
influenza virus followed by administration of SAD responded with significantly lower (p < 0.05) antibody
titers to influenza virus than mice exposed to influenza virus alone.
Introduction
Secalonic acid D (SAD) is a metabolite ofPenicillium
oxalicum (1) andAspergillus aculeatus (2). Penicillium
oxalicum isolated from grain crops intended for con-
sumption by domestic animals and humans has been as-
sociated with adverse effects in animals consuming con-
taminated grains (3-5). Detectable quantities of SAD
were present in grain dust samples collected from ter-
minal grain elevators located in the lower Mississippi
River region (6). Grain dusts contaminated with SAD
pose potential health hazards for workers from occupa-
tional exposure to the dust, and for animals given feed
composed ofpelleted grain dust.
Secalonic acid D has been reported as having toxic
effects in laboratory animals. The LD50 for male ICR
mice administered SAD intraperitoneally (IP) was cal-
culated to be 31 mg/kg with deaths occurring between
2 and 8 days (4,7). Following the intravenous injection of
SAD, the mycotoxin was found to concentrate inthe liver
and kidneys (8). Pathological examinations revealed that
SAD injected IP caused adhesions and peritonitis asso-
ciated with the diaphragm, stomach, intestines, abdom-
inal wall, liver, and kidneys (4,7). Hepatic portal and
parenchymal necrosis was also evident. In anotherstudy,
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it was reported that pulmonary atelectasis, pulmonary
vascular congestion, and hemorrhaging occurred in mice
following the IP injection ofSAD (5,7). In addition, Sor-
enson et al. (9) observed lung abnormalities in rats when
SAD was administered intratracheally.
This study was initiated to discern the role mycotoxin
exposure might have in the progression of an infectious
disease in livestock and humans. The mycotoxin SAD
waschosenbecauseitwasfoundasanaturalcontaminant
in grain dust and reported to be a causative agent in
lungpathology. Therefore, the purpose ofthis study was
to determine the effect of administering SAD to labo-
ratory mice previously exposed to aerosols of influenza
virus.
Materials and Methods
Experimental Animals
Animals used in this study were male ICR mice (King
Laboratories, Middleton, WI) weighing between 25 and
30 g each. Mice were maintained in temperature-con-
trolled rooms at 18°C with 12 hr light/dark cycles. Pel-
leted feed and fresh water were available ad libitum.
Animals were acclimated for 1 week prior to treatment.
Influenza Virus
The AiChi (H2N3) strain of influenza virus was fur-
nished by Dr. Ken Soike (Tulane University, Delta Re-
gional Primate Center, Covington, LA). A pool of virus
was prepared by one passage in embryonated chickenFLEISCHHACKER ET AL.
Table 1. Experimental groups.
Treatment
Experimental group Day 0 Day 5
Untreated control
DMSO (vehicle only) - DMSO/bicarbonatea
SAD only SADb
Flu only Aerosol exposure
Flu/DMSO Aerosol exposure DMSO/bicarbonate
Flu/SAD Aerosol exposure SAD
aO.1 mL of 10% DMSO in 5% sodium bicarbonate.
b35 mg/kg body weight administered IP.
eggs followed by harvesting the allantoic fluids. The al-
lantoic fluid (stock virus) titered 10-72 egg infectious
doses (EID5o)/mL and was stored at -70°C until used.
Aerosol Exposure
A modified Henderson aerosol apparatus similar to
that previously described by Akers et al. (10) was used
for the aerosol exposure ofmice to influenza virus. A De
Vilbis type 40 atomizer was used to aerosolize the virus
suspension. The atomizer containing 5.5 mL of a 1:50
dilution ofthe virus suspension in Minimal Essential Me-
dium (MEM) (Flow Laboratories, McLean, VA) was op-
erated under 10 lb of air pressure and at a constant air
flow of 12.5 L/min. Mice, in groups of20, were exposed
for 5 min receiving a dose of 366 EID50 units. An AGI-
30 impinger was operated continuously during the ex-
posure periods. Allaerosol runs were conducted withthe
aerosol apparatus operating within a Class II, Type B
biological safety cabinet.
Secalonic Acid D Preparation and Adminis-
tration
Flasks of yeast extract (2%)-sucrose (5%) medium
were inoculated with Penicillium oxalicum (NRRL
5209). Secalonic acid D wasextractedfromthesecultures
according to the method of Ciegler et al. (5). Purified
SAD was dissolved in DMSO and further diluted with
5% aqueous sodium bicarbonate to yield a final DMSO
concentration of 10%. Throughout this study, a dose of
35 mg SAD/kg ofbody weight was administered IP in a
volume not to exceed 0.1 mL ofSAD solution/30 gofbody
weight. The SAD solution was injected IP 5 days after
the mice were exposed to influenza virus aerosols. The
DMSO control mice received 0.1 mL ofDMSO diluted in
5% aqueous sodium bicarbonate to give a final concen-
tration of 10% DMSO. The experimental regime employed
is depicted in Table 1.
Mortality Studies
Mortality rate and the time of death were determined
for the following groups: Flu, Flu/SAD, SAD, and Flu/
DMSO. A group of untreated mice was maintained as
controls. Mice were observed twice a day for up to 14
days after aerosol exposure to influenza virus. The har-
monic mean time ofdeath ofeach ofthe four groups was
determined and compared using the Kruskal-Wallis test
(11). The chi-square test for two independent variables
was used to determine ifSAD had a significant effect on
the number of deaths from influenza infection.
Viral Pathogenesis
Virusreplication inthe lungs ofmice inthefourgroups
as well as fromDMSO and untreated controlgroups were
determined in lungs removed aseptically on days 0, 3, 9,
and 12 following aerosol exposure. Lung tissues from
each group (four mice per group at each time interval),
were pooled, homogenized, and suspended in MEM with
10%fetalbovine serumtogiveafinal 10%w/vsuspension.
Tenfold serial dilutions ofthe lung suspensions were pre-
pared, and 0.1 mL of each dilution was inoculated into
the allantoic sac of five 10-day-old embryonated chicken
eggs. Allantoic fluids from each egg were harvested 48
hr later and individually tested for hemagglutination ac-
tivity. Humantype 0 bloodwasobtainedbyvenipuncture
and placed into heparinized tubes. The red blood cells
(RBC) were washed three times and resuspended to a
final concentration of0.75% in phosphate-buffered saline
(PBS). The allantoicfluid (0.2mL) wasmixed thoroughly
with 0.8 mL ofPBS and 0.5 mL ofthe RBC suspension.
The tubes were incubated at room temperature for 1 hr
and then examined forhemagglutination. Those dilutions
with positive hemagglutination were used in calculating
the 50% egg infective dose (EID50) by the method of
Reed and Muensch (12).
Histopathology
On days 0, 3, 6, 9, and 12 following aerosol exposure,
spleens were removed from four mice randomly selected
from each ofthe six groups ofmice (Flu, Flu/SAD, SAD,
Flu/DMSO, DMSO, and untreated controls). Following
inflation of the lungs with 10% formalin, the lungs and
spleens were fixed in the formalin solution, dehydrated
with ethanol, embedded in paraffin and sectioned into 6-
,umsections. Sections were stainedwithhematoxylin and
eosin and examined by light microscopy. Mice that were
moribund or had just recently died were examined in
terms of gross pathology and histopathology.
Hemagglutination Inhibition Assay
Blood was collected from mice in the Flu, Flu/SAD,
SAD, and untreated control groups 21 days after aerosol
exposure. Sera from five mice were pooled and heat in-
activated at560Cfor30min. Thepooled serawerediluted
1:5 in PBS. The diluted sera (0.5 mL) were mixed with
0.5 mL of25% kaolin, an absorbant (Flow Laboratories,
McLean, VA) and incubated at room temperature for 2
hr with occasional shaking. After centrifugation of the
mixture at 1,000g for 10 min, the supernatant was re-
moved and the serum incubated with 0.1 mL of packed
human type 0 RBC for 1 hr at room temperature. The
suspension was centrifuged and the supernatant re-
moved. Twofold dilutions were made in V-bottom micro-
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FIGURE 1. Cumulative mortality: (e)S group; (N)SF group; (L)F
group.
titer plates such that each well contained 0.05 mL of
diluted serum, 0.05 mL ofdiluted virus, and 0.05 mL of
1% human type 0 RBC. The plates were incubated at
room temperature for 1 hr. Hemagglutination inhibition
(HAI) titers were the reciprocal of the highest dilution
ofserum causingthe inhibition ofhemagglutination. The
virus dilution used consisted of a 1:4 suspension of the
hemagglutination titer.
Results
Mortality Studies
The mean time of death for the Flu and Flu/SAD
groups ofmice was 8.78 and 8.96 days, respectively, fol-
lowing virus aerosol exposure. The Kruskal-Wallis test
indicated SAD administration to influenza infected mice
did not significantly affect the mean time ofdeath. Mice
in the SAD only group had a mean death time of 5.52
days following SAD injection. This corresponded to day
10.52 after influenza virus exposure. The cumulative
times of death are shown in Figure 1. Secalonic acid D
administered alone resulted in 25% ofthe mice dying (15
of60), whereas influenzaalone produced amortality rate
of 28% (17 of 60). The two agents together (Flu/SAD)
resulted in amortality rate of82% or82 of100test mice.
Using the chi-square test for two independent samples
SAD significantly (p < 0.001) increased the mortality
rate among influenza-infected mice.
Viral Pathogenesis
Influenza virus replication (increases in EIDso with
time) was determined by titrating lung homogenates de-
rived from each experimental group. The SAD, un-
treatedcontrol, and DMSO groupspresentednoevidence
ofinfluenza virus infection throughout the study period
Table 2. Virus titers (EIDw) in lung tissues.
Virus titer EID50 at various times
after influenza virus exposure
0 3 5 6 9 12
Experimental group days days days days days days
Untreated control 0 0 a 0 0 0
DMSO a 0 0 0
SAD only a 0 0 0
Flu only 0 10-69 a 10-66 10-25 0
Flu/DMSO a 10-5-5 10-2o0 0
Flu/SAD a 10-6.5 10-44 0
aOn day 5 SAD or DMSO was administered.
(Table 2). This indicated that there was little or no cross
contamination between cages. In mice exposed to virus
aerosols, thevirustiterspeakedat3daysafterexposure.
On day 5, DMSO was injected into infected mice (Flu/
DMSO) and resulted in a slight decrease in virus titers
on the following day. After day 6 similar declines in lung
homogenate EID50 occurred in Flu and Flu/DMSO
groups until day 12 when no virus was detected. Influ-
enza-infected mice that were administered SAD (Flu/
SAD) exhibited a slowerrecovery from virus infection as
evidence by higher virus titers on days 6 and 9 than the
Flu/DMSO group. Mice in this group (Flu/SAD) that
survived to day 12 had no evidence of continuing viral
replication in lung tissues.
Histopathology
Organ Weights. The weights ofspleens and lungs as
a percent oftotal body weights were determined for the
mice in the different experimental groups (Table 3). No
significant difference was evident in spleen weights
among the various groups of mice at different times or
with different treatment regimes. The weights of lungs
on day 9 were significantly higher (p > 0.025) than those
on days 6 and 12 for the virus-infected groups. There
was also a significant increase (p < 0.001) in the weight
oflungs between those groups exposed to influenza aer-
osols (Flu, Flu/SAD and Flu/DMSO) and those groups
not exposed to influenza (untreated control, DMSO, and
SAD) on days 6 and 9.
Lung Pathology. Mice from SAD, DMSO, and un-
treated control groups were generally free from lung le-
sions, although some background changes were noted.
These background changes included a few small, focal
paravascular or parabronchiolar lymphoid aggregates.
Small areas ofintraalveolar hemorrhage and atelectasis
that were also present may have been artifacts produced
atnecropsy. Nohistopathologicdifferences wereobserved
in lung tissues of Flu and untreated control group mice
sacrificed onday 0. The Flugroupbyday3 had extensive
areas ofnecrotic bronchiolar epithelium and bronchiolar
lumens were ifiled with necrotic cellular debris. Acute
interstitial pneumonia was present in small areas. Al-
veolar spaces were partially collapsed and also contained
necrotic cellular debris. Observations on day 6 after in-
fluenza exposure were similar to those seen 3 days after
exposure, except that the epithelium remaining in the
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Table 3. Weight of organs as percent of total body weight at
various times after virus exposure.
Organ weight at various times after
virus exposurea
Spleen Lung
6 9 12 6 9 12
Experimental group days days days days daysb days
Untreated control 0.42 0.35 0.37 0.82 0.91 0.78
DMSO 0.45 0.39 0.44 0.89 1.04 0.81
SAD 0.42 0.43 0.50 0.90 0.91 0.69
Flu 0.42 0.53 - 1.19c 1.19c
Flu/DMSO 0.54 0.55 0.47 1.33c 1.78c 1.29c
Flu/SAD 0.51 0.37 0.47 1.09c 1.64c 1.28c
aNo significant difference between treatment groups or times fol-
lowing virus exposure.
bARl mice exposed to influenza virus aerosols had significant in-
creases in lung weights.
CDay 9 mice exposed to influenza virus aerosols exhibited an in-
crease in lung weights when compared to days 6 and 12.
bronchioles and alveolar lining cells were slightly hyper-
plastic. The interstitial pneumonia was more extensive
and severe than was observed for day 3. On day 9, less
necrosis ofbronchiolarepitheliumandbronchiolarinflam-
mation were observed. The interstitial pneumonia was
more chronic in appearance on day 9 than on day 6.
Extensive alveolar lining cell and bronchial hyperplasia
weredominantonday12. Theinflammationwasresolving
at this time, although there were areas of intraalveolar
edema in Flu, Flu/DMSO, and Flu/SAD groups. There
was no apparent histopathologic difference between mice
in the Flu and Flu/SAD groups.
Spleens. Spleens from DMSO, SAD, and untreated
controlgroups appeartobenormalinallrespects. Those
spleens from mice in groups Flu, Flu/SAD, and Flu/
DMSO showed increases in lymphoid hyperplasia and ex-
tramedullary hematopoiesis on days 9 and 12. However,
there was no significant difference between the three
groups in question.
Spontaneous Deaths. Histopathologic findings for
the mice dying spontaneously or found to be moribund
on days 6 and 7 after aerosol exposure (1 to 2 days after
SAD administration) were similar to those mice sacri-
ficed from the different groups in accordance with the
study schedule described above. Pneumonia was severe
andpulmonary edemawas evident inthose mice exposed
to influenza aerosols. Mice administered SAD only ex-
hibited minimal to moderate necrosis of the liver. Mice
from the Flu/SAD group exhibited both pneumonia and
liver necrosis (Fig. 2). Livers from mice in other groups
were not examined. Three of the eleven mice receiving
SADpossessed adarkreddish-brown fluid intheirstom-
achs and small intestines.
Hemagglutination Inhibition Assay Results
The mean serum HAI titer for those mice exposed to
virus only was 332, while the mean HAI titer for mice
exposed to Flu and SAD (Flu/SAD) was 187. This Flu/
SAD titer was significantly lower (p < 0.05) than that
for mice ofthe Flu group. The HAI titer for mice from
the SAD group was 5.5. The control groups (DMSO and
untreated controls) had no antibody response to the in-
fluenza virus whatsoever.
Discussion
There have been several reports which employ respi-
ratory virus infections to studythe role ofenvironmental
agents in alteringthe host's susceptibility to respiratory
infections (13,14). Since SAD is a known contaminant of
grain dusts (6), and has been reported to produce lung
damage (5,7,9) experiments were designed to monitor
effects SAD might have on the altered susceptibility of
mice to influenza infections. This was important for the
elucidation of the role ofthis grain dust contaminant in
respiratory influenza infections.
Indeed, when SAD was administered to mice infected
with influenza virus, an increase in mortality was ob-
served. The resultant 82% mortality rate for the Flu/
SAD group compared to the Flu rate of 28% and SAD
rate of 25% indicated more than an additive effect be-
tween the two agents and suggested a possible syner-
gistic effect. While the mortality rate increased with the
combination of Flu and SAD the mean time ofdeath for
mice exposed toinfluenza virus aerosols was not altered.
Animals in the Flu and Flu/SAD groups died approxi-
mately 9 days after aerosol exposure.
Assessmentofvirusreplicationinlungtissuesrevealed
thatthegreatestvirusreplicationoccurredbetweendays
3 and 6 after aerosol exposure and declined thereafter.
MiceintheFlu/SADgroupappearedtohavehighervirus
titers than the Flu/DMSO group. But by day 12, all sur-
viving animals showed no signs ofresidual virus in their
lung tissues.
Whenthe lungs fromthe differentgroups ofmice were
weighed it was found that the weights of the lungs ob-
tainedfrommiceexposedtoinfluenzaaerosolsweremuch
higherthantheweightofthelungsfrommicenotexposed
toinfluenzavirus. Thelungweightsonday9afteraerosol
exposure were significantly higher (p > 0.025) than for
days 6 and 12. The higher lung weights for the virus-
infected mice could be attributed to edema. The patho-
logicalcourse ofthe influenzainfectionwas characterized
by maximal lung damage by day 9 followed by the initi-
ation of the recovery process. No differences were ob-
served between the extent or degree ofinfection in Flu,
Flu/SAD, andFlu/DMSO groups ofmice. Miceexamined
after spontaneous death 2 to 3 days post-SAD adminis-
tration exhibited moderate liver necrosis in addition to
the lungpathology, which was characteristic ofinfluenza.
Data from the present study suggest that the lung ab-
normalities previouslyreportedformiceinjected IPwith
SAD (5,7) may be only an artifact ofnecropsy.
There has been no evidence presented to date that
related influenza infections to liver damage. Therefore,
the liverpathology seen in the SAD treated mice and its
similarity with the Flu/SAD groups were attributed to
the effects of SAD alone and not due to its interaction
with the influenza virus infection. It has been reported
that the biotransformation of drugs by hepatic micro-
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FIGURE 2. Hispathology observed in Flu/SAD mice dying 2 days after SAD administered: (a) lung tissue indicative of chromic pneumonia,
magnified x 140; (b) liver where arrows delineate normal from necrotic areas, magnified x 160.
somes was decreased following stimulation of host de-
fense mechanisms by a number of agents including in-
terferon and viruses (15). Although the mechanism for
SAD metabolism has not been elucidated it is thought
that SAD is metabolized by the liver, since conjugates of
SAD have been found in the bile. A decrease in SAD
metabolism could possibly explain the elevated mortality
rates for the Flu/SAD groups of mice.
Those mice dying from SAD (SAD and Flu/SAD
groups) exhibited signs of mild tremors, lethargy, and
withdrawalandcessationofeatinganddrinking. Inthese
two groups, there were very few mice alive after days 9
and 12, which precluded the sampling and assaying of
the prescribed number of mice as originally projected.
However, it was observed that those mice surviving
among the SAD or Flu/SAD groups did not exhibit overt
signs ofillness. The variability ofresponses to SAD ob-
served in this study may indicate differences in the ef-
ficiency ofindividual mice to metabolize SAD. Reddy et
al. (7) reported a wide range of LD50 values based on
strain, sex, and age of the laboratory animal.
The HAI test results indicated that at 21 days after
influenza virus aerosol exposure, there was a significant
difference in the Flu and Flu/SAD groups' humoral im-
mune responses. It is apparent that SAD significantly
suppressed the antibody response to influenza virus in-
section. Yamamoto (16) has previously reported that tu-
mor cells exposed to SAD showed aninhibition ofprotein
synthesis. Apossible mechanism forthe in vivo suppres-
sionofantibodyformationobservedintheFlu/SADgroup
may be explained by Yamamoto's in vitro findings.
Several studies have indicated that various mycotoxins
maypossessimmunosuppressive properties (17-19). Any
compromise in the immune system may result in an im-
pairment of the host's ability to control microbial path-
ogens. This in turn could lead to infections and possible
death ofthe host. Further studies to investigate the im-
munotoxic effects of SAD are currently underway.
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